BHUBANESWAR: Punching holes within the much-hyped Niramaya free drug distribution scheme and Well being for All initiative of the State authorities, the Comptroller and Auditor Basic (CAG) of India has uncovered large irregularities by the Odisha State Medical Company Ltd (OSMCL) in procurement of medication and medical consumables together with displaying undue favour to suppliers.
Coming down closely on the Well being and Household Welfare division for the intense lapses, the CAG identified that the State authorities has failed to make sure unbroken provide of important medicine to sufferers in public well being establishments as per its personal prescribed Important Medicine Listing (EDL).
The Odisha authorities had launched the Niramaya scheme in 2016 below which sufferers are being offered medicine freed from value in any respect public well being amenities within the State. The OSMCL below the Well being division has been entrusted with procurement and provide of the medicine, medical consumables and tools.
The audit, performed for the years from 2016 to 2019, revealed that the procurement course of was riddled with systemic flaws and there was an inordinate delay in finalisation of annual procurement plans for medicine, medical consumables and tools, devices and furnishings (EIFs).
The OSMCL might provide solely 49 per cent (computer) of the indented/accredited amount of medication and medical consumables to well being establishments throughout 2016-19.
Non-supply of indented amount resulted in non-availability of important medicine in well being amenities.
The audit has additionally revealed that below the federal government’s flagship KHUSHI scheme for well being and hygiene of ladies and woman youngsters, sanitary napkins had been procured at greater costs whereas undue favour was proven to a selected agency for procurement of spectacles below Sunetra Yojana for common eyecare.
The State Drug Administration Committee (SDMC) had accredited 524 to 596 sorts of medication and medical consumables to the tune of 692.97 crore items for procurement throughout 2016-19, however the OSMCL might solely get 336.94 crore items.
Owing to the delay, the well being establishments procured domestically and incurred extra expenditure.
CAG punches holes in Niramaya scheme, flags irregularities by OSMCL
The audited well being establishments had incurred extra expenditure of Rs 98.12 lakh (44 per cent) in procuring medicines value Rs 2.24 crore throughout 2018-19. Equally, OSMCL might procure solely 43 computer EIF in opposition to the accredited amount throughout 2016-19.
As of June 2019, 19 computer of the procured EIF had not been put in and had been mendacity unutilised. Ineffective monitoring of indents, distribution, consumption, inventory place of medication by way of e-Niramaya software program led to the expiry of medication valued at Rs 4.18 crore throughout April 2017 to Could 2019,” the report acknowledged.
The CAG stated lack of monitoring on the degree of Well being division/ State Drug Administration Unit/ OSMCL and well being establishments finally resulted in a scarcity of important medicine and wastage of presidency sources as a result of expiry of unused gadgets, equipped in extra.
Even because the Well being division in August final 12 months claimed that OSMCL procured medicine on the premise of consumption at well being amenities, and equipped medicines and anticancer medicine as per indents, the CAG stated the reply was not tenable as brief/non provide of indented medicine resulted in inventory out of important medicines in well being amenities resulting in the indenting officers having to acquire unavailable medicine domestically at a lot greater charges.
As per contract situations, OSMCL ought to de-recognise/blacklist the defaulting suppliers and forfeit earnest cash deposit and efficiency safety of the stated bidder/ provider.
The audit noticed that the company had not recovered/forfeited efficiency securities of suppliers amounting to Rs 47.42 lakh in respect of 30 out of 252 buy orders (POs) issued throughout 2016-19 in opposition to which there was no provide.
OSMCL had additionally not taken different penal actions like de-recognition/blacklisting or cancellation of POs, in opposition to the defaulting companies.
Surprisingly, 17 companies, which had been ‘nil’ suppliers in earlier years had been unduly favoured by OSMCL by award of additional contracts valued at Rs 55.45 crore in subsequent years.
Lackadaisical strategy of the company in finalisation of tender led to non-functioning of blood part separation items at Balasore, Baripada, Keonjhar, Koraput, Bargarh, Balangir, and Rourkela and idling of apparatus value Rs 4.47 crore, the report acknowledged.
The SEMC had additionally accredited procurement of 890 EIF for Sardar Vallavbhai Patel Publish Graduate Institute of Paediatrics (SVPPGI) at Rs 9.28 crore.
Although the approval was granted in 2015-16, the OSMCL took about three years to produce this stuff indicating its apathetic strategy to procurement, the report acknowledged.
199 to 204 important medicine and consumables to the tune of 356.03 crore items accredited for 2016-19 weren’t procured in any respect.
As per e-Niramaya database for 2018-19, 151 to 260 varieties of medicine had been in brief provide whereas 29 to 100 had been over equipped.
The OPD beneficiaries’ survey revealed 141 of 555 prescription drugs weren’t distributed to the sufferers.
Throughout 2016-19, OSMCL had positioned 3,471 buy orders (POs) with 484 companies for provide of medication and consumables value Rs 568.65 crore. However, solely 70 computer of the POs had been totally executed and 23 computer partially.